Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the manifestations of anxiety in children with autism spectrum disorders.
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, Dukes K, Vitiello B, Gadow K, Scahill L. Hallett V, et al. Among authors: hollander e. J Autism Dev Disord. 2013 Oct;43(10):2341-52. doi: 10.1007/s10803-013-1775-1. J Autism Dev Disord. 2013. PMID: 23400347 Free PMC article.
Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.
Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A. Scahill L, et al. Among authors: hollander e. J Autism Dev Disord. 2012 Mar;42(3):432-40. doi: 10.1007/s10803-011-1251-8. J Autism Dev Disord. 2012. PMID: 21667200 Clinical Trial.
Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. King BH, et al. Among authors: hollander e. JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698. JAMA Pediatr. 2013. PMID: 24061784 Free PMC article. Clinical Trial.
Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder.
Bradshaw J, Gillespie S, McCracken C, King BH, McCracken JT, Johnson CR, Lecavalier L, Smith T, Swiezy N, Bearss K, Sikich L, Donnelly C, Hollander E, McDougle CJ, Scahill L. Bradshaw J, et al. Among authors: hollander e. J Autism Dev Disord. 2021 Sep;51(9):3039-3049. doi: 10.1007/s10803-020-04625-x. J Autism Dev Disord. 2021. PMID: 33151499 Free PMC article.
Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors.
Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, King BH, McCracken JT, Scahill L, Sikich L, Pickles A. Simonoff E, et al. Among authors: hollander e. J Child Adolesc Psychopharmacol. 2022 May;32(4):233-241. doi: 10.1089/cap.2021.0137. Epub 2022 May 2. J Child Adolesc Psychopharmacol. 2022. PMID: 35501967 Free PMC article. Clinical Trial.
Large multicenter randomized trials in autism: key insights gained from the balovaptan clinical development program.
Jacob S, Anagnostou E, Hollander E, Jou R, McNamara N, Sikich L, Tobe R, Murphy D, McCracken J, Ashford E, Chatham C, Clinch S, Smith J, Sanders K, Murtagh L, Noeldeke J, Veenstra-VanderWeele J. Jacob S, et al. Among authors: hollander e. Mol Autism. 2022 Jun 11;13(1):25. doi: 10.1186/s13229-022-00505-6. Mol Autism. 2022. PMID: 35690870 Free PMC article.
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network. King BH, et al. Among authors: hollander e. Arch Gen Psychiatry. 2009 Jun;66(6):583-90. doi: 10.1001/archgenpsychiatry.2009.30. Arch Gen Psychiatry. 2009. PMID: 19487623 Free PMC article. Clinical Trial.
A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
Umbricht D, Del Valle Rubido M, Hollander E, McCracken JT, Shic F, Scahill L, Noeldeke J, Boak L, Khwaja O, Squassante L, Grundschober C, Kletzl H, Fontoura P. Umbricht D, et al. Among authors: hollander e. Neuropsychopharmacology. 2017 Aug;42(9):1914-1923. doi: 10.1038/npp.2016.232. Epub 2016 Oct 6. Neuropsychopharmacology. 2017. PMID: 27711048 Free PMC article. Clinical Trial.
In Search of Biomarkers for Autism Spectrum Disorder.
Del Valle Rubido M, McCracken JT, Hollander E, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. Del Valle Rubido M, et al. Among authors: hollander e. Autism Res. 2018 Nov;11(11):1567-1579. doi: 10.1002/aur.2026. Epub 2018 Oct 15. Autism Res. 2018. PMID: 30324656 Free PMC article.
574 results